Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology

JP Radich, M Deininger, CN Abboud, JK Altman… - Journal of the National …, 2018 - jnccn.org
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome
(Ph), resulting from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] that …

Can targeting the incretin pathway dampen RAGE-mediated events in diabetic nephropathy?

KC Sourris, H Yao, G Jerums, ME Cooper… - Current Drug …, 2016 - ingentaconnect.com
Diabetic nephropathy is the major cause of end-stage renal disease in Western societies. To
date, interruption of the Renin-Angiotensin System is the most effective intervention for …

Circulating miR-146a expression predicts early treatment response to imatinib in adult chronic myeloid leukemia

EM Habib, NA Nosiar, MA Eid… - Journal of …, 2021 - journals.sagepub.com
This study aimed to investigate the prognostic role of circulating miR-146a in the prediction
of early response to imatinib treatment in patients with chronic myeloid leukemia (CML) …

Higher red blood cell distribution width is an adverse prognostic factor in chronic-phase chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

N Iriyama, Y Hatta, S Kobayashi, Y Uchino… - Anticancer …, 2015 - ar.iiarjournals.org
The significance of red blood cell distribution width (RDW) was evaluated in patients with
chronic myeloid leukemia (CML) in the chronic phase (CP). Eighty-four patients with newly …

[HTML][HTML] Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary …

LC Kuntegowdanahalli, GB Kanakasetty… - …, 2016 - ncbi.nlm.nih.gov
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder. Over the years many
prognostic models have been developed to better risk stratify this disease at baseline. Sokal …

Higher red blood cell distribution width is a poor prognostic factor for patients with chronic myeloid leukemia

T Li, X Li, H Chen, KZ Huang, Q Xie, HY Ge… - Cancer Management …, 2021 - Taylor & Francis
Purpose Red blood cell distribution width (RDW) has been considered as a potential
indicator of the effects of treatment or as a prognostic indicator for various malignancies …

Combination of white blood cell count at presentation with molecular response at 3 months better predicts deep molecular responses to imatinib in newly diagnosed …

YZ Qin, Q Jiang, H Jiang, YY Lai, HH Zhu, YR Liu… - Medicine, 2016 - journals.lww.com
Combination of White Blood Cell Count at Presentation With M... : Medicine Combination of
White Blood Cell Count at Presentation With Molecular Response at 3 Months Better …

Validation of the EUTOS long-term survival score in Chinese chronic myeloid leukemia patients treated with imatinib: a multicenter real-world study

X Yang, Y Bai, M Shi, W Zhang, J Niu… - Cancer Management …, 2020 - Taylor & Francis
Purpose To validate the clinical efficacy of the recently developed EUTOS long-term survival
(ELTS) score in a real-world setting. Patients and Methods A total of 479 chronic myeloid …

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase …

S Chhikara, S Sazawal, K Singh… - South Asian Journal …, 2018 - thieme-connect.com
Introduction: The ultimate goal for CML management is risk stratification of the patients to
design the appropriate treatment approach. The Sokal, Euro and EUTOS risk scores were …

Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor

M Uemura, O Imataki, Y Kawachi, K Kawakami… - International journal of …, 2016 - Springer
Abstract Although the Sokal and Hasford scoring systems are well-known prognostic models
specific to chronic myeloid leukemia (CML), whether they can effectively predict outcomes in …